Clinical trials: Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine
Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine
Named Patient Program With Rotigotine Transdermal System
The named patient program will allow investigators to supply rotigotine transdermal system to patients who have a documented medical necessity to receive treatment with the drug.
- Trial name
- NCT01095484
- Testing
- Rotigotine patch
- Where
- 51 sites in United States
- Volunteers
- 520 people
- Sponsor
- UCB Pharma